GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Price-to-Funds-From-Operations

Noxopharm (ASX:NOX) Price-to-Funds-From-Operations : (As of Jun. 09, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Noxopharm (ASX:NOX) Business Description

Industry
Traded in Other Exchanges
Address
60 Linksley Ave, Glenhaven, NSW, AUS, 2156
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.